MiR-143 Targeting TAK1 Attenuates Pancreatic Ductal Adenocarcinoma Progression via MAPK and NF-κB Pathway In Vitro.
about
MiR-143 inhibits endometrial cancer cell proliferation and metastasis by targeting MAPK1.MicroRNA-143 promotes cardiac ischemia-mediated mitochondrial impairment by the inhibition of protein kinase Cepsilon.MiR-143-3p suppresses the progression of ovarian cancer.MicroRNA Roles in the Nuclear Factor Kappa B Signaling Pathway in Cancer.The mechanism of miR-143 inducing apoptosis of liver carcinoma cells through regulation of the NF-κB pathway.Resibufogenin suppresses transforming growth factor-β-activated kinase 1-mediated nuclear factor-κB activity through protein kinase C-dependent inhibition of glycogen synthase kinase 3
P2860
MiR-143 Targeting TAK1 Attenuates Pancreatic Ductal Adenocarcinoma Progression via MAPK and NF-κB Pathway In Vitro.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
MiR-143 Targeting TAK1 Attenua ...... PK and NF-κB Pathway In Vitro.
@en
type
label
MiR-143 Targeting TAK1 Attenua ...... PK and NF-κB Pathway In Vitro.
@en
prefLabel
MiR-143 Targeting TAK1 Attenua ...... PK and NF-κB Pathway In Vitro.
@en
P2093
P2860
P1476
MiR-143 Targeting TAK1 Attenua ...... PK and NF-κB Pathway In Vitro.
@en
P2093
Chu-Qiang Li
Feng-Ting Huang
Juan-Fei Peng
Ling-Yun Wang
Shi-Neng Zhang
Wen-Jie Cheng
Wen-Ying Chen
Yan-Yan Zhuang
Yuan-Hua Li
P2860
P2888
P304
P356
10.1007/S10620-017-4472-7
P577
2017-02-13T00:00:00Z
P6179
1083805783